Meliva 10 mg (Tablet)
Unit Price: ৳ 8.06 (3 x 10: ৳ 241.80)
Strip Price: ৳ 80.60
Medicine Details
| Category | Details |
|---|---|
| Generic | Escitalopram oxalate |
| Company | Jayson pharmaceuticals ltd |
Title
- Meliva
- Escitalopram Oxalate Tablets
Categories
- Antidepressant
- Anxiolytic
- Selective Serotonin Reuptake Inhibitor (SSRI)
Description
- Indications:
- Treatment of major depressive episodes
- Treatment of panic disorder with or without agoraphobia
- Treatment of social anxiety disorder (social phobia)
- Treatment of generalised anxiety disorder
- Treatment of obsessive-compulsive disorder
- Pharmacology: Escitalopram is an orally administered SSRI with potent inhibition of 5-HT reuptake
- Dosage:
- Safe daily dose: Not demonstrated above 20 mg
- Usual dosage for major depressive episodes: 10-20 mg once daily
- Initial dose for panic disorder: 5 mg then increase to 10-20 mg daily
- Initial dose for social anxiety disorder: 10 mg, may increase to 20 mg daily
- Initial dose for generalised anxiety disorder: 10-20 mg once daily
- Initial dose for obsessive-compulsive disorder: 10-20 mg once daily
- Administration: Administered once daily, morning or evening, with or without food
- Interaction: Avoid starting MAOI until 2 weeks after stopping SSRI, and vice versa
- Contraindications:
- Hypersensitivity to Escitalopram or Citalopram
- Concomitant use with MAOI/pimozide
- Side Effects:
- Less sedating than tricyclic antidepressants
- Common side effects include gastrointestinal effects, anorexia, weight changes, hypersensitivity reactions, dry mouth, nervousness, headache, insomnia, tremor, dizziness, sexual dysfunction, and more
- Pregnancy & Lactation: Physician should carefully consider risks and benefits of treatment during the third trimester, excreted in breast milk
- Precautions & Warnings: Caution in patients with epilepsy, cardiac disease, diabetes, glaucoma, bleeding disorders, hepatic and renal impairment
- Use in Special Populations:
- Dosage adjustment in elderly patients
- Not recommended for children and adolescents
- Caution in patients with renal, hepatic impairment, and poor metabolizers of CYP2C19
- Overdose Effects:
- Symptoms include central nervous system, gastrointestinal, cardiovascular, and electrolyte/fluid balance conditions
- Management involves maintaining airway and oxygenation, gastric lavage, activated charcoal, ECG monitoring
- Therapeutic Class: SSRIs & related anti-depressant drugs
- Storage Conditions: Store below 30°C, protect from light & moisture, keep out of reach of children